Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
13.06
+0.49 (3.90%)
At close: Nov 6, 2026, 4:00 PM EST
13.24
+0.18 (1.38%)
Pre-market: Nov 9, 2026, 7:01 AM EST

Generate Biomedicines Revenue

Generate Biomedicines had revenue of $6.31M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $26.48M. In the year 2025, Generate Biomedicines had annual revenue of $31.89M with 55.89% growth. That makes Generate Biomedicines the 32,175th largest company in the world by revenue and 4,235th in the United States.

Revenue (ttm)
$26.48M
Revenue Growth
+55.89%
P/S Ratio
63.30
Revenue / Employee
$84,881
Employees
312
Market Cap
1.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202531.89M11.43M55.89%
Dec 31, 202420.46M--